Clinically insignificant changes of chest CT in the nelfinavir treated patients
pneumonia
DISEASE, PNEUMONIA
On the day 7 of treatment, subjects with mild disease did not progress to pneumonia in either group. On the 14th day of treatment for the chest CT results of moderate COVID-19, one patient was abnormal and had no clinical significance in the nelfinavir group, whereas three individuals in the control group were abnormal and clinically significant, with no discernible difference between the two groups statistically. On the 14th day of treatment for patients with mild COVID-19, there were no subjects in either the nelfinavir group (